XML 22 R15.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

Accounts Payable and Accrued Expenses | 3 Months Ended
--- | ---
Mar. 31, 2024
Payables and Accruals [Abstract] |
Accounts Payable and Accrued Expenses | 6. Accounts Payable and Accrued Expenses: Accounts payable and accrued expenses consist of the following (in thousands):
|  | March 31, 2024 |  | December 31, 2023
Accounts payable |  | $31,636 |  | $34,588
Accrued salaries and incentive compensation |  | 65,711 |  | 193,112
Accrued payroll taxes and benefits |  | 23,674 |  | 36,545
Accrued professional liabilities |  | 29,034 |  | 32,039
Accrued interest |  | 2,936 |  | 8,262
Other accrued expenses |  | 54,044 |  | 46,252
|  | $207,035 |  | $350,798
The net decrease in accrued salaries and incentive compensation of $127.4 million, from December 31, 2023 to March 31, 2024, is primarily due to the payment of performance-based incentive compensation, principally to the Company’s affiliated physicians, partially offset by performance-based incentive compensation accrued during the three months ended March 31, 2024. A majority of the Company’s payments for performance-based incentive compensation is paid annually during the first quarter.

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration